Livzon Pharmaceutical Group (HK:1513) has released an update.
Livzon Pharmaceutical Group Inc. has announced an ordinary final cash dividend of RMB 13.5 per 10 shares for the year ended December 31, 2023, with an exchange rate of RMB 1 to HKD 1.0978, resulting in a HKD 14.8203 per 10 share payout for shareholders. The shareholders’ approval date is June 14, 2024, with the dividend payable by August 5, 2024. Withholding tax rates for non-resident enterprises and resident individuals are set at 10% and 20%, respectively.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
